本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Intellia Therapeutics Inc

12.05
+0.31022.64%
成交量:136.02萬
成交額:1,620.50萬
市值:16.87億
市盈率:-3.60
高:12.11
開:11.66
低:11.66
收:11.74
52周最高:28.25
52周最低:7.95
股本:1.40億
流通股本:1.38億
量比:0.62
換手率:0.99%
股息:- -
股息率:- -
每股收益(TTM):-3.3456
每股收益(LYR):-3.8100
淨資產收益率:-55.44%
總資產收益率:-30.14%
市淨率:2.32
市盈率(LYR):-3.16

資料載入中...

2020/03/26

重要事件披露

Current report, item 8.01
2020/03/13

重要事件披露

Current report, items 1.01 and 2.03
2020/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2019/12/16

重要事件披露

Current report, item 8.01
2019/10/31

重要事件披露

Current report, items 2.02 and 9.01
2019/10/31

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/09/26

重要事件披露

Current report, item 8.01
2019/09/10

SEC問詢函

[Cover]Correspondence
2019/09/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/30

SEC問詢函

[Cover]Correspondence
2019/08/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals